Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)
CUSIP: 04746L104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 Par Value
- Shares outstanding
- 9,614,000
- Total 13F shares
- 17,923,414
- Share change
- +1,794,542
- Total reported value
- $10,513,884
- Put/Call ratio
- 4.6%
- Price per share
- $0.59
- Number of holders
- 54
- Value change
- +$1,168,387
- Number of buys
- 11
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04746L104:
Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
56%
|
5,402,964
|
$2,409,722 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
17%
|
1,613,063
|
$719,426 | — | 30 Sep 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
16%
|
1,492,792
|
$665,785 | — | 30 Sep 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
16%
|
1,492,792
|
$665,785 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
6.2%
|
600,000
|
$267,600 | — | 30 Sep 2024 | |
| Hans Moebius |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
91,482
|
$266,213 | — | 04 Jan 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.6%
|
535,543
|
$238,852 | — | 30 Sep 2024 | |
| Pathstone Holdings, LLC |
13F
|
Company |
5.1%
|
492,126
|
$219,488 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
5%
|
476,502
|
$211,000 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.7%
|
452,787
|
$201,943 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
4.5%
|
428,778
|
$191,235 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
4.1%
|
397,111
|
$177,000 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
3.5%
|
337,600
|
$150,570 | — | 30 Sep 2024 | |
| Bristlecone Advisors, LLC |
13F
|
Company |
3.5%
|
337,506
|
$150,528 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.3%
|
321,447
|
$143,365 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.3%
|
320,844
|
$143,131 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2.7%
|
258,473
|
$115,279 | — | 30 Sep 2024 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
1.5%
|
147,309
|
$65,700 | — | 30 Sep 2024 | |
| Andrew Gengos |
3/4/5
|
CFO and Chief Business Officer |
—
mixed-class rows
|
377,532
mixed-class rows
|
$55,203 | — | 03 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
107,781
|
$48,070 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.92%
|
88,893
|
$39,646 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.86%
|
82,350
|
$37,053 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.66%
|
63,033
|
$28,113 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
53,609
|
$23,910 | — | 30 Sep 2024 | |
| Clarius Group, LLC |
13F
|
Company |
0.56%
|
53,551
|
$23,884 | — | 30 Sep 2024 | |
| Invst, LLC |
13F
|
Company |
0.47%
|
45,000
|
$20,070 | — | 30 Sep 2024 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.42%
|
40,227
|
$17,941 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.35%
|
34,012
|
$15,169 | — | 30 Sep 2024 | |
| EASTERLY INVESTMENT PARTNERS LLC |
13F
|
Company |
0.35%
|
33,500
|
$14,941 | — | 30 Sep 2024 | |
| Integrity Financial Corp /WA |
13F
|
Company |
0.34%
|
32,786
|
$14,623 | — | 30 Sep 2024 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.33%
|
32,200
|
$14,361 | — | 30 Sep 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.31%
|
29,348
|
$13,000 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.28%
|
27,149
|
$12,109 | — | 30 Sep 2024 | |
| Rachel Lenington |
3/4/5
|
COO and CDO |
—
mixed-class rows
|
320,870
mixed-class rows
|
$11,812 | — | 03 Sep 2024 | |
| JOURNEY STRATEGIC WEALTH LLC |
13F
|
Company |
0.21%
|
20,538
|
$9,160 | — | 30 Sep 2024 | |
| SIMON QUICK ADVISORS, LLC |
13F
|
Company |
0.21%
|
20,538
|
$9,160 | — | 30 Sep 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.21%
|
20,242
|
$9,028 | — | 30 Sep 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.21%
|
20,000
|
$8,920 | — | 30 Sep 2024 | |
| StoneX Group Inc. |
13F
|
Company |
0.21%
|
19,753
|
$8,810 | — | 30 Sep 2024 | |
| Sargent Investment Group, LLC |
13F
|
Company |
0.2%
|
19,516
|
$8,704 | — | 30 Sep 2024 | |
| Mirador Capital Partners LP |
13F
|
Company |
0.2%
|
19,454
|
$8,676 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
18,351
|
$8,185 | — | 30 Sep 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.17%
|
16,468
|
$7,345 | — | 30 Sep 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.16%
|
15,062
|
$6,718 | — | 30 Sep 2024 | |
| Larson Financial Group LLC |
13F
|
Company |
0.16%
|
15,000
|
$6,690 | — | 30 Sep 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.13%
|
12,468
|
$6,000 | — | 30 Sep 2024 | |
| ROTHSCHILD INVESTMENT LLC |
13F
|
Company |
0.13%
|
12,900
|
$5,753 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
11,828
|
$5,276 | — | 30 Sep 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
11,000
|
$4,906 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
10,118
|
$4,513 | — | 30 Sep 2024 |
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q4 2024
As of 31 Dec 2024,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,923,414 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BML Capital Management, LLC, VANGUARD GROUP INC, Propel Bio Management, LLC, Simplify Asset Management Inc., TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., ACADIAN ASSET MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, and Pathstone Holdings, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
56
Q4 2024 holders
54
Holder diff
-2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.